Phesgo 1200mg/600mg/30.000 units s.c. sol. for inj. 15 ml Online Shopping
التصنيف: antineoplastic المادة الفعالة:pertuzumab+trastuzumab+hyaluronidase
indications: 1-early breast cancer. phesgoï- (pertuzumab trastuzumab and hyaluronidase-zzxf) is indicated for use in combination with chemotherapy for **the neoadjuvant treatment of adult patients with her2-positive locally advanced inflammatory or early
